Wells Fargo Initiates Coverage of Viridian Therapeutics (VRDN) with Overweight Recommendation
18/4 04:20
Fintel reports that on April 17, 2023, Wells Fargo initiated coverage of Viridian Therapeutics (NASDAQ:VRDN) with a Overweight recommendation....